Zhang Yan, Qu Xin, Qu Peng Peng
Department of Obstetrics & Gynecology, Tianjing Medical University, Tianjin, China.
J BUON. 2016 Nov-Dec;21(6):1491-1495.
This study was conducted to analyze the predictive value of circulating tumor cells (CTC) expressing thyroid transcription factor-1 (TTF-1) on the recurrence and survival rates of endometrial carcinoma patients treated with laparoscopic surgery.
78 patients were recruited, diagnosed with endometrial carcinoma and measured CTC expressing TTF-1 using flow cytometry in blood and tissues. Then, the patients were distributed into TTF-1-positive (N=42) and -negative (N=36) groups. The levels of HE4 were determined by ELISA, the levels of cancer antigen CA125 and CA15.3 by chemiluminescent immunoassay, and the levels of mRNA expression of survivin, β-catenin, miR-15a, and PTEN by RT-PCR assay from endometrial carcinoma samples.
Patients in TTF-1-positive group had mainly TNM stages II and III-IV, whereas the TTF-1-negative group stages I and II predominated. The rates of vascular infiltration and lymphatic metastasis in the TTF-1-positive group were higher compared with the TTF-1-negative group (p<0.05). The serum levels of CA125, CA15.3, and HE4 were significantly higher in the TTF-1-positive group than in the TTF-1-negative group (p<0.05). The levels of survivin and β-catenin mRNA expression in endometrial carcinoma in the TTF-1-positive group was higher than in the TTF-1-negative group. In contrast, the levels of miR-15a and PTEN mRNA expression were lower in the TTF-1-positive group (p<0.05). The median follow-up duration was 25 months for both groups. At that time, progression-free survival (PFS) and the median survival time decreased in the TTF-1-positive group compared with the TTF-1-negative group. Additionally, the recurrence rate increased in the TTF-1-positive group.
The rate of TTF-1-positive CTC was strongly correlated with TNM staging, vascular infiltration, lymphatic metastasis, and the levels of CA125, CA15.3, and HE4 in endometrial carcinoma. The levels of survivin, β-catenin, miR-15a, and PTEN mRNA also contributed to predict survival rates after laparoscopic surgery.
本研究旨在分析表达甲状腺转录因子-1(TTF-1)的循环肿瘤细胞(CTC)对接受腹腔镜手术治疗的子宫内膜癌患者复发率和生存率的预测价值。
招募78例被诊断为子宫内膜癌的患者,采用流式细胞术检测血液和组织中表达TTF-1的CTC。然后,将患者分为TTF-1阳性组(N = 42)和阴性组(N = 36)。通过酶联免疫吸附测定(ELISA)法测定HE4水平,通过化学发光免疫分析法测定癌抗原CA125和CA15.3水平,并通过逆转录聚合酶链反应(RT-PCR)法测定子宫内膜癌样本中生存素、β-连环蛋白、miR-15a和PTEN的mRNA表达水平。
TTF-1阳性组患者主要为TNM分期II期和III-IV期,而TTF-1阴性组以I期和II期为主。与TTF-1阴性组相比,TTF-1阳性组的血管浸润率和淋巴转移率更高(p<0.05)。TTF-1阳性组的血清CA125、CA15.3和HE4水平显著高于TTF-1阴性组(p<0.05)。TTF-1阳性组子宫内膜癌中生存素和β-连环蛋白的mRNA表达水平高于TTF-1阴性组。相反,TTF-1阳性组中miR-15a和PTEN的mRNA表达水平较低(p<0.05)。两组的中位随访时间均为25个月。此时,与TTF-1阴性组相比,TTF-1阳性组的无进展生存期(PFS)和中位生存时间缩短。此外,TTF-1阳性组的复发率增加。
TTF-1阳性CTC率与子宫内膜癌的TNM分期、血管浸润、淋巴转移以及CA125、CA15.3和HE4水平密切相关。生存素、β-连环蛋白、miR-15a和PTEN的mRNA水平也有助于预测腹腔镜手术后的生存率。